Association Between Peripheral Blood CD19-Positive Rate and Antibody-Mediated Rejection Following Rituximab Administration in Kidney Transplant Recipients

BACKGROUND. Rituximab is used widely for desensitization in ABO-incompatible and donor-specific antibody-positive kidney transplantation. However, data about the effects of individual differences in rituximab-induced B-cell suppression on antibody-mediated rejection (AMR) remain unknown. We aimed to...

Full description

Saved in:
Bibliographic Details
Published in:Transplant Direct
Main Authors: Nanmoku, Koji, Shinzato, Takahiro, Kubo, Taro, Shimizu, Toshihiro, Yagisawa, Takashi
Format: Artigo
Language:Inglês
Published: Wolters Kluwer Health 2019
Subjects:
Kidney Transplantation
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6616141/
https://ncbi.nlm.nih.gov/pubmed/31334341
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/TXD.0000000000000907
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items